Deepika R. Sriram

Deepika Sriram practices at Aurora St. Luke's Medical Center in Milwaukee, Wisconsin, part of Advocate Health.

Deepika Sriram's NPI, 1902224678, was assigned on March 31, 2014. Deepika Sriram graduated from University of Illinois College of Med (Chi/Peor/Rock/Chm-Urb) in 2014. Deepika Sriram holds Wisconsin license 64916.

Deepika Sriram's primary practice is Aurora St. Luke's Medical Center, at 2900 W Oklahoma Ave, Milwaukee, WI 53215 in Milwaukee County. The practice phone is (414) 649-6000.

Deepika Sriram's primary practice is Aurora St. Luke's Medical Center in Milwaukee, Wisconsin, part of Advocate Health. The medical group on file is Froedtert & the Medical College of Wisconsin Community Physicians. Dmand AI also links Deepika Sriram to 3 more medical groups and 1 therapy and rehab clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Deepika Sriram practices, 2 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Deepika Sriram's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Deepika Sriram is licensed in Wisconsin.

CMS data shows 141 Medicare services from Deepika Sriram across 3 procedure codes in 2024, for 34 Medicare patients. Medicare paid $7,650 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 34 Medicare patients who saw Deepika Sriram in 2024. The largest group is 65 to 74, with 22 patients. 75% of them have cancer, and 53% have high cholesterol. Their average risk score is 1.87, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Deepika Sriram's median patient age at 69, with 77% women.

In 2024, Deepika Sriram wrote 88 Medicare Part D claims for 29 patients. 82% of them were for generic drugs. CMS names the drug for 39 of them, across 3 drugs with 11 or more claims each, at $180,381 in total drug cost. In 2023, CMS named 52 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Deepika Sriram for performance year 2024, reported as part of a group. Deepika Sriram accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Deepika Sriram in 2020. Deepika Sriram's most frequent co-authors are Saurabh Chhabra, MD, Binod Dhakal, MD and Anita D'Souza, MD.

CMS Open Payments shows 3 general payments to Deepika Sriram from 2 drug and device companies from 2017 to 2024. Consulting fees make up the largest share, 99% of the total. AstraZeneca Pharmaceuticals LP paid the most, $1,050.

Deepika Sriram graduated from University of Illinois College of Med (Chi/Peor/Rock/Chm-Urb) in 2014.